Prophylaxis and Therapy of Venous Thromboembolism

References

• Abemethy E. A., Hartsuck J. M. Postoperative pulmonary embolism. A prospective study utilizing low dose heparin. Am. J. Surg. 1974; 128: 739
   Google Scholar
• Babcock R. B., Dumper C. W., Scharfman W. B. Heparin-induced immune thrombocytopenia. N. Engl. J. Med. 1976; 295: 237
   PubMed Web of Science ®Google Scholar
• Basu D., Gallus A., Hirsh J., Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N. Engl. J. Med. 1972; 287: 324
   PubMed Web of Science ®Google Scholar
• Bell W. R., Tomasulo R. A., Alving B. M., Duffy T. P. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann. Intern. Med. 1976; 85: 155
   PubMed Web of Science ®Google Scholar
• Covey T. H., Sherman L., Baue A. E. Low-dose heparin in postoperative patients. A prospective, coded study. Arch. Surg. (Chicago) 1975; 110: 1021
   PubMedGoogle Scholar
• Fratantoni J. C., Pollet R., Gralnick H. R. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood 1975; 45: 395
   PubMed Web of Science ®Google Scholar
• Galasko C. S. B., Edwards D. H., Fearn C. B. D'A., Barber H. M. The value of low dosage heparin for the prophylaxis of thromboembolism in patients with transcervical and intertrochanteric femoral fractures. Acra Orthop. Scand. 1976; 47: 276
   PubMed Web of Science ®Google Scholar
• Gallus A. S., Hirsh J., Tuttle R. J., Trebilcock R., O'Brien S. E., Carroll J. J., Minden J. H., Hudecki S. M. Small subcutaneous doses of heparin in prevention of venous thrombosis. N. Engl. J. Med. 1973; 288: 545
   PubMed Web of Science ®Google Scholar
• Gallus A. S., Hirsh J., O'Brien S. E., McBride J. A., Tuttle R. J., Gent M. Prevention of venous thrombosis with small, subcutaneous doses of heparin. JAMA 1976; 235: 1980
   PubMed Web of Science ®Google Scholar
• Glazier R. L., Crowell E. B. Randomized prospective trial of continuous vs. intermittent heparin therapy. JAMA 1976; 236: 1365
   PubMed Web of Science ®Google Scholar
• Gruber U. F., Fridrich R., Duckert F., Torhorst J., Rem J. Prevention of postoperative thromboembolism by Dextran 40, low doses of heparin, or Xantinol nicotinate. Lancet 1977; 1: 207
   PubMed Web of Science ®Google Scholar
• Habersberger P. G., Pitt A., Anderson S. T. Venous thromboses in myocardial infarction. Comparison in heparin dosage. Br. Heart J. 1973; 35: 538
   Google Scholar
• Hampson W. G. J., Lucas H. K., Harris F. C., Roberts P. H., McCall I. W., Jackson P. C., Powell N. L., Staddon G. E. Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty. Lancet 1974; 2: 795
   PubMed Web of Science ®Google Scholar
• Handley A. J., Emerson P. A., Fleming P. R. Heparin in the prevention of deep vein thrombosis after myocardial infarction. Br. Med. J. 1972; 2: 436
   PubMedGoogle Scholar
• International Multicentre Trial, Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 1975; 2: 45
   PubMed Web of Science ®Google Scholar
• International Multicentre Trial, Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 1977; 1: 567
   Google Scholar
• Kakkar V. V., Spindler J., Flute P. T., Corrigan T., Fossard D. P., Crellin R. Q., Wessler S., Yin E. T. Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomized trial. Lancet 1972; 2: 101
   PubMedGoogle Scholar
• Mant M. J., Thong K. L., Birtwhistle R. V., O'Brien B. D., Hammond G. W., Grace M. G. Haemorrhagic complications of heparin therapy. Lancet 1977; 1: 1133
   PubMed Web of Science ®Google Scholar
• Morris G. K., Henry A. P. J., Preston B. J. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet 1974; 2: 797
   Google Scholar
• McCarthy S. T., Robertson D., Turner J. J., Hawkey C. J., Macey D. J. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 1977; 2: 800
   PubMed Web of Science ®Google Scholar
• Pachter H. L., Ryles T. S. Low-dose heparin: bleeding and wound complications in the surgical patient. A prospective randomized study. Ann. Surg. 1977; 186: 669
   PubMed Web of Science ®Google Scholar
• Pitney W. R., Pussell B. A., Harris M., Manohar D. The subcutaneous use of heparin in the prevention of venous thrombosis after myocardial infarction. Med. J. Aust. 1974; 1: 38
   Google Scholar
• Sagar S. Heparin prophylaxis against fatal postoperative pulmonary embolism. Br. Med. J. 1974; 2: 153
   Google Scholar
• Sagar S., Massey J., Sanderson J. M. Low-dose heparin prophylaxis against fatal pulmonary embolism. Br. Med. J. 1975; 4: 257
   PubMedGoogle Scholar
• Sagar S., Stamatakis J. D., Higgins A. F., Nairn D., Maffei F. H., Thomas D. P., Kakkar V. V. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet 1976; 1: 1151
   PubMed Web of Science ®Google Scholar
• Salzman E. W., Deykin D., Shapiro R. M., Rosenberg R. Management of heparin therapy. Controlled prospective trial. N. Engl. J. Med. 1975; 292: 1046
   PubMed Web of Science ®Google Scholar
• Venous Thrombosis Clinical Study Group, Small doses of subcutaneous sodium heparin in the prevention of deep vein thrombosis after elective hip operations. Br. J. Surg. 1975; 62: 348
   PubMed Web of Science ®Google Scholar
• Warlow C., Terry G., Kenmure A. C. F., Beattie A. G., Ogston D., Douglas A. S. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet 1973; 2: 934
   PubMed Web of Science ®Google Scholar
• Jaques L. B. The pharmacology of heparin and heparinoids. Prog. Med. Chan. 1967; 5: 139
   Google Scholar
• Ehrlich J., Stivala S. S. Chemistry and pharmacology of heparin. Review article. J. Pharm. Sci. 1973; 62: 517
   PubMed Web of Science ®Google Scholar
• Nader H. B., McDuffie N. M., Dietrich C. P. Heparin fractionation by electrofocusing; presence of 21 components of different molecular weights. Biochem. and Biophys. Res. Commun. 1971; 57: 488
   Google Scholar
• Abildgaard U. Heparin cofactor and antithrombin. Thromb. Diath. Haemorrh. 1974; 33: 38
   Google Scholar
• Yin E. T. Effect of heparin on the neutralization of Factor Xa and thrombin by the plasma alpha-2-globulininhibitor. Thromb. Diath. Haemorrh. 1974; 33: 43
   Google Scholar
• Rosenberg R. D., Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 1973; 248: 6490
   PubMed Web of Science ®Google Scholar
• Rosenberg R. D. Heparin action. Circulation 1974; 49: 603
   PubMed Web of Science ®Google Scholar
• Yin E. T., Wessler S., Stoll P. J. Biological properties of the naturally occurring plasma inhibitor to activated Factor X. J. Biol. Chem. 1971; 246: 3703
   PubMed Web of Science ®Google Scholar
• Sharnoff J. O. Prevention of sudden cardio-pulmonary arrest in the perioperative period with prophylactic heparin. Lancet 1969; 2: 292
   PubMed Web of Science ®Google Scholar
• Kakkar V. V., Spindier J., Flute P. T., Corrigan T., Fossard D. P., Crellin R. Q., Wessler S., Yin E. T. Efficacy of low-doses of heparin in prevention of deep-vein thrombosis after major surgery; a double-blind randomized trial. Lancet 1972; 2: 101
   PubMedGoogle Scholar
• Oallus A. S., Hirsh J., Turtle R. J., Trebilcock R., O'Brien S. E., Carroll J. J., Minden J. H., Hudecki S. M. Small subcutaneous doses of heparin in prevention of venous thrombosis. N. Engl. J. Med. 1973; 288: 545
   Google Scholar
• Gallus A. S., Hirsh J., O'Brien S. E., McBride J., Turtle R. J., Gent M. Prevention of venous thrombosis with small subcutaneous doses of heparin. JAMA 1976; 235: 1980
   PubMed Web of Science ®Google Scholar
• Williams H. T. Prevention of postoperative deep vein thrombosis with perioperative subcutaneous heparin. Lancet 1971; 2: 950
   PubMed Web of Science ®Google Scholar
• Gordon-Smith I. C., LeQuesne L. P., Grundy O. J., Newcome J. F. Controlled trial of two regimens of sub-cutaneous heparin in prevention of post-operative deep-vein thrombosis. Lancet 1972; 1: 1133
   PubMedGoogle Scholar
• Nicolaides A. N., Desai S., Douglas J. N., Fourides G., Dupont P. A., Lewis J. D., Dodsworth H., Luck K. J., Jamieson C. W. Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 1972; 2: 890
   PubMed Web of Science ®Google Scholar
• Ballard R. M., Bradley-Watson P. J., Johnstone F. D., Kenney A., McCarthy T. G., Campbell S., Weston J. Low dose of subcutaneous heparin in the prevention of deep vein thrombosis after gynecological surgery. J. Obstet. Gynaecol. Br. Commonw. 1973; 80: 469
   PubMedGoogle Scholar
• Lahnborg G., Friman L., Bergstrom K., Lagergren H. Effect of low-dose heparin on incidence of post-operative pulmonary embolism detected by photoscanning. Lancet 1974; 1: 329
   PubMedGoogle Scholar
• Scottish Study, A multi-unit controlled trial, heparin versus dextran in the prevention of deep-vein thrombosis. Lancet 1974; 1: 118
   Google Scholar
• Rosenberg I. L., Evans M., Pollock A. V. Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial. Br. Med. J. 1975; 1: 649
   PubMed Web of Science ®Google Scholar
• Rem J., Duckert F., Fridric R., Gruber U. R. Subkutane klein heparin dosen zur thrombose-prophylaxe in der allgemeinen Chirurgie and Urologie. Schweiz. Med. Wochenschr. 1975; 105: 827
   PubMedGoogle Scholar
• International Multicentre Trial, Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 1975; 2: 45
   PubMed Web of Science ®Google Scholar
• Hirsh J., Genton E. Low-dose Heparin Prophylaxis for Venous Thromboembolism. Prophylactic Therapy of Deep Vein Thrombosis and Pulmonary Embolism, J. Fratantoni, S. Wessler. Publication No. 76–866, National Institute of Health, U.S. Department of Health, Education, and Welfare, U.S. Government Printing Office, Washington, D. C 1975
   Google Scholar
• Abernethy E. A., Hartsuck J. M. Postoperative pulmonary embolism. A prospective study utilizing low dose heparin. Am. J. Surg. 1974; 128: 739
   PubMedGoogle Scholar
• Covey T. H., Sherman L., Baue A. E. Low-dose heparin in postoperative patients. A prospective, coded study. Arch. Surg. (Chicago) 1975; 110: 1021
   PubMedGoogle Scholar
• Dechavanne M., Soudin F., Viala J. J., Kher A., Bertrix L., DeMourgues G. Prevention des thromboses veneuses. Succes de I'heparin a fortes doses lors des coxarthroses. Nouv. Presse Med. 1974; 3: 1317
   PubMedGoogle Scholar
• Hume M., Kuriakose T., Xavier Z. L., Turner R. H. 126I-fibrinogen and the prevention of venous thrombosis. Arch. Surg. (Chicago) 1973; 107: 803
   Google Scholar
• Evarts C. M., Alfidi J. Thromboembolism after total hip reconstruction; failure of low doses of heparin in prevention. JAMA 1973; 225: 515
   Web of Science ®Google Scholar
• Hampson W. G. J., Harris F. C., Lucas H. K., Roberts P. H., McCall I. W., Jackson P. C., Powell N. L., Staddon G. E. Failure of low-dose heparin to prevent deep-vein thrombosis after hip replacement arthroplasty. Lancet 1974; 2: 795
   PubMed Web of Science ®Google Scholar
• Morris G. K., Henry A. P. J., Preston B. J. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet 1974; 2: 797
   Google Scholar
• Venous Thrombosis Clinical Study Group, Small doses of subcutaneous heparin in the prevention of deep vein thrombosis after elective hip operations. Br. J. Surg. 1975; 62: 348
   PubMed Web of Science ®Google Scholar
• Sagar S., Stamatakis J. D., Higgins A. F., Nairn D., Maffei F. H., Thomas O. P., Kakkar V. V. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet 1976; 1: 1151
   PubMed Web of Science ®Google Scholar
• Galasko C. S. B., Edwards D. H., Fearn C. B. D'A., Barber H. M. The value of low dosage heparin for the prophylaxis of thromboembolism in patients with transcervical and intertrochanteric femoral fractures. Acta Orthop. Scand. 1976; 47: 276
   PubMed Web of Science ®Google Scholar
• Warlow C., Terry G., Kenmure A. C. F., Beattie A. G., Ogston D., Douglas A. S. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet 1973; 2: 934
   PubMed Web of Science ®Google Scholar
• Handley A. J. Low-dose heparin after myocardial infarction. Lancet 1972; 2: 623
   PubMed Web of Science ®Google Scholar
• Handley A. J., Emerson P. A., Fleming P. R. Heparin in the prevention of deep vein thrombosis after myocardial infarction. Br. Med. J. 1972; 2: 436
   PubMedGoogle Scholar
• Pitney W. R., Pussell B. A., Harris M., Manohar D. The subcutaneous use of heparin in the prevention of venous thrombosis after myocardial infarction. Med. J. Aust. 1974; 1: 38
   Google Scholar
• Habersberger P. G., Pitt A., Anderson S. T. Venous thromboses in myocardial infarction. Comparison in heparin dosage. Br. Heart J. 1973; 35: 538
   Google Scholar
• McCarthy S. T., Robertson D., Turner J. J., Hawkey C. J., Macey D. J. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 1977; 2: 800
   PubMed Web of Science ®Google Scholar
• Sherry S. Low-dose heparin prophylaxis for postoperative venous thromboembolism. N. Engl. J. Med. 1975; 293: 300
   Google Scholar
• Gruber U. F., Fridrich R., Duckert F., Torhorst J., Rem J. Prevention of postoperative thromboembolism by Dextran 40, low doses of heparin, or Xantinol nicotinate. Lancet 1977; 1: 207
   PubMed Web of Science ®Google Scholar
• International Multicentre Trial, Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 1977; 1: 567
   Google Scholar
• Sagar S., Massey J., Sanderson J. M. Low-dose heparin prophylaxis against fatal pulmonary embolism. Br. Med. J. 1975; 4: 257
   PubMedGoogle Scholar
• Sagar S. Heparin prophylaxis against fatal postoperative pulmonary embolism. Br. Med. J. 1974; 2: 153
   Google Scholar
• Pachter H. L., Ryles T. S. Low-dose heparin: bleeding and wound complications in the surgical patient. A prospective randomized study. Ann. Surg. 1977; 186: 669
   PubMed Web of Science ®Google Scholar
• Barritt D. W., Jordan S. C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; 1: 1309
   PubMed Web of Science ®Google Scholar
• Basu D., Gallus A., Hirsh J., Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N. Engl. J. Med. 1972; 287: 324
   PubMed Web of Science ®Google Scholar
• Salzman E. W., Deykin D., Shapiro R. M., Rosenberg R. Management of heparin therapy. Controlled prospective trial. N. Engl. J. Med. 1975; 292: 1046
   PubMed Web of Science ®Google Scholar
• Glazier R. L., Croweü E. B. Randomized prospective trial of continuous vs. intermittent heparin therapy. JAMA 1976; 236: 1365
   PubMed Web of Science ®Google Scholar
• Mant M. J., Thong K. L., Birtwhistle R. V., O'Brien D. B., Hammond G. W., Grace M. G. Haemorrhagic complications of heparin therapy. Lancet 1977; 1: 1133
   PubMed Web of Science ®Google Scholar
• Murray G., MacKenzie R. Postoperative thrombosis and embolism. Am. J. Surg. 1942; 57: 414
   Google Scholar
• Cox J. S. T. The maturation and canalization of thrombi. Surg. Gynecol. Obstet. 1963; 116: 593
   Google Scholar
• Coon W. W., Willis P. W., III. Thromboembolic complications during anticoagulant therapy. Arch. Surg. (Chicago) 1972; 105: 209
   PubMedGoogle Scholar
• Coon W. W., Willis P. W., III. Recurrence of venous thromboembolism. Surgery 1973; 73: 823
   PubMed Web of Science ®Google Scholar
• Griffith G. C., Nichols G., Asher J. D. Heparin osteoporosis. JAMA 1965; 193: 85
   Web of Science ®Google Scholar
• Sackler J. P., Liu L. Heparin-induced osteoporosis. Br. J. Radiol. 1973; 46: 548
   PubMed Web of Science ®Google Scholar
• Douglas A. S. Anticoagulant Therapy. Blackwell Scientific, Oxford 1962
   Google Scholar
• Bernstein I. L. Anaphylaxis to heparin sodium. JAMA 1956; 161: 1379
   PubMed Web of Science ®Google Scholar
• Curry N., Bardana E. J., Pirofsky B. Heparin sensitivity. Arch. Intern. Med. 1973; 132: 744
   Google Scholar
• Bell W. R., Tomasulo R. A., Alving B. M., Duffy T. P. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann. Intern. Med. 1976; 85: 155
   PubMed Web of Science ®Google Scholar
• Fratantoni J. C., Pollet R., Gralnick H. R. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood 1975; 45: 395
   PubMed Web of Science ®Google Scholar
• Babcock R. B., Dumper C. W., Scharfman W. B. Heparin-induced immune thrombocytopenia. N. Engl. J. Med. 1976; 295: 237
   PubMed Web of Science ®Google Scholar
• Powers P., Hirsh J. 1978, personal communication
   Google Scholar
• Turpie A. G. G., Hirsh J., Gent M. 1978, unpublished observations
   Google Scholar